Degenerative Disc Disease Treatment Market Analysis, Growth, Trends And Revenue By Top Key Players - Medtronic Plc, Zimmer Biomet, Paradigm Spine, Globus Medical

Degenerative disc disease is a spinal condition caused by the breakdown of your intervertebral discs. The symptoms observed for degenerative disc disease are tingling or numbness in legs or difficulty walking. This disease is diagnosed with physical examination, through X-rays or magnetic resonance imaging (MRI). The degenerative disc disease is most commonly seen in geriatric population and a cause of low back pain and neck pain in adults. The common cases of back pain among patients occurs at the lower side of the back and is known as lower back pain. As per American Association of Neurological Surgeons in 2016, 75-85% of people in the U.S. experience some form of back pain in their life.

Key players operating in the global degenerative disc disease treatment market includes Medtronic Plc, Zimmer Biomet, Paradigm Spine, Globus Medical, Cousin Biotech, Ulrich Medical and SpineVision.

Ask For A Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1280

North America market accounted for the largest share in the degenerative disc disease treatment market, followed by Europe market in 2016. This is attributed due to increasing number of clinical trials in U.S. for degenerative disc disease treatment. For instance, Centinel Spine is planning to commence clinical trials with the Nova, Vivo and Oblique technologies, currently sold outside of the U.S.

In December 2017, Camber Spine announced that this company has received U.S. Food and Drug Administration (FDA) clearance to market its SPIRA-C, Open Matrix Cervical Interbody device. This clearance marks Camber's second implant clearance in the SPIRA family of implant systems to be released in the U.S. market, indicated for use at one or two contiguous levels in the cervical spine, in skeletally mature patients who have had six weeks of non-operative treatment for the degenerative disk disease (DDD) with up to Grade 1 spondylolisthesis.

Furthermore, the Spinal Kinetics, Inc., the designer and manufacturer of the M6 artificial disc, announced in June 2017, that the total implantations of the company’s M6-C Cervical and M6-L Lumbar discs have exceeded 50,000 throughout the international markets where the M6 is commercially available. This fact supports the growing demand of degenerative disc disease treatment market.

The recent advances in technology helps the degenerative disc disease treatment market to augment in near future. For instance, in 2016, according to data published in Journal of Neurosurgery: Spine, the ProDisc technology has proven clinical efficacy in the U.S. It was also found. Authors of the study found total disc replacement with ProDisc-C that the procedure is also cost-effective compared to spinal fusion and recorded an average of US $12,789 in savings which is more effective than spinal fusion for single-level procedures.

Download The Pdf Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1280

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.